Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Cyanation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102649973A details a high-purity enzymatic route for (S)-bufuralol. Discover cost-effective manufacturing and reliable supply chain solutions for this critical pharmaceutical intermediate.
Patent CN101848916A reveals a titanium catalyst for asymmetric cyanation. This report analyzes cost reduction in API manufacturing and supply chain reliability for high-purity intermediates.
Patent CN111620860B reveals a streamlined synthesis for Afuresertib, eliminating complex protection steps for significant cost reduction and supply chain reliability in AKT inhibitor manufacturing.
Novel two-step route for Remdesivir intermediate CN111205294A. Enhanced chiral purity, reduced cost, scalable manufacturing for global pharma supply chains.
Patent CN111620793B details a copper-catalyzed asymmetric trifluoromethyl cyanation method offering high enantioselectivity and mild conditions for reliable pharmaceutical intermediate manufacturing.
Patent CN106748853B reveals high-yield asymmetric synthesis for Clopidogrel intermediates. Achieve substantial cost reduction and supply chain reliability.
Novel patent CN114751853B enables safer synthesis of key antiviral intermediates. Achieve high purity and yield without toxic cyanide. Reliable supply chain partner.
Patent CN102603566B details a room-temperature asymmetric synthesis of chiral amino nitriles using copper catalysis, offering mild conditions for pharmaceutical intermediate manufacturing.